Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
| ▸ | BRS3 | P32247 | 3/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.45 |
| ▸ | AURKA | O14965 | 1/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.43 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | CSF1R | P07333 | 1/20 | 0.43 |
| ▸ | RET | P07949 | 1/20 | 0.43 |
| ▸ | MET | P08581 | 1/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.43 |
| ▸ | PIM1 | P11309 | 1/20 | 0.43 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.43 |
| ▸ | FLT3 | P36888 | 1/20 | 0.43 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | CDK8 | P49336 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12173603 | 0.88 | KIF11 (0.48) | NPC1ABL1KIF11KDM1AMAOB | |
| SCHEMBL14062459 | 0.86 | KIF11 (0.52) | NPC1ABL1KIF11KDM1AMAOB | |
| SCHEMBL26023954 | 0.85 | KDM1A (0.53) | KIF11CYP11B1CYP11B2ALOX5APKDM1A | |
| SCHEMBL11976427 | 0.84 | NPC1 (0.46) | NPC1RXFP1PTPN1PTPN6PTPN11 | |
| SCHEMBL22079741 | 0.83 | TSHR (0.52) | NPC1AURKAABL1NTRK1LCK | |
| SCHEMBL556994 | 0.83 | KIF11 (0.56) | NPC1RXFP1PTPN1PTPN6PTPN11 | |
| SCHEMBL11976441 | 0.82 | NPC1 (0.45) | NPC1RXFP1PTPN1PTPN6PTPN11 | |
| SCHEMBL14848446 | 0.82 | JAK2 (0.42) | NPC1RXFP1BRS3KCNH2RET | |
| SCHEMBL12622265 | 0.81 | NPC1 (0.50) | NPC1BRS3KCNH2ABL1KIF11 | |
| SCHEMBL25557996 | 0.81 | TSHR (0.50) | NPC1AURKAABL1NTRK1LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230371358-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230365606-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230357296-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-09 | — | — | US | disclosed |
| US-20230348510-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230345812-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230345811-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230337521-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230337522-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230331756-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230337523-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230263049-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337522-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, EML4, LBR | NPC1 1803/4885RXFP1 3192/4885PTPN1 1789/4885 |
| US-20230345812-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OPRD1, OCIAD2 | NPC1 2835/4885RXFP1 90/4885PTPN1 3478/4885 |
| US-20230357296-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OPRD1, OXER1, LBR | NPC1 1942/4885RXFP1 116/4885PTPN1 2840/4885 |
| US-20230337523-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, OCIAD1, OCIAD2 | NPC1 2775/4885RXFP1 131/4885PTPN1 4191/4885 |
| US-20230331756-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, SSB, LBR | NPC1 1856/4885RXFP1 503/4885PTPN1 2009/4885 |
| US-20230337521-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, NR1H2 | NPC1 2199/4885RXFP1 745/4885PTPN1 4691/4885 |
| US-20230263049-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBPL3, OCIAD1, OSBP | NPC1 1370/4885RXFP1 4160/4885PTPN1 4586/4885 |
| US-20230348510-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, OXER1, OXSR1 | NPC1 2404/4885RXFP1 364/4885PTPN1 3517/4885 |
| US-20230371358-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LIFR, SOD1, ROS1 | NPC1 4515/4885RXFP1 770/4885PTPN1 4057/4885 |
| US-20230365606-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OXER1, OPRD1, OXSR1 | NPC1 3499/4885RXFP1 228/4885PTPN1 3318/4885 |
| US-20230345811-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OPRD1, L1CAM, OPRM1 | NPC1 1706/4885RXFP1 1967/4885PTPN1 4307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.